234 related articles for article (PubMed ID: 9879410)
1. Risk factors for adverse systemic reactions occurring during immunotherapy with standardized Dermatophagoides farinae extracts.
Ohashi Y; Nakai Y; Tanaka A; Kakinoki Y; Washio Y; Ohno Y; Yamada K; Nasako Y
Acta Otolaryngol Suppl; 1998; 538():113-7. PubMed ID: 9879410
[TBL] [Abstract][Full Text] [Related]
2. Systemic tolerability of specific subcutaneous immunotherapy with index-of-reactivity-standardized allergen extracts administered using clustered regimens: a retrospective, observational, multicenter study.
Serrano P; Justicia JL; Sánchez C; Cimarra M; Fernández-Távora L; Orovitg A; Moreno C; Guerra F; Alvà V
Ann Allergy Asthma Immunol; 2009 Mar; 102(3):247-52. PubMed ID: 19354072
[TBL] [Abstract][Full Text] [Related]
3. [Safety analysis of dust mite allergen for diagnosis and immunotherapy of asthma and rhinitis].
Wen T; Cai Y; Chen X; Xiang L; Wang B; Zhuang Y
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1999; 17(5):274-6. PubMed ID: 12563856
[TBL] [Abstract][Full Text] [Related]
4. [Preventive immunotherapy].
Boquete M; Carballada F; Expósito F; González A
Allergol Immunopathol (Madr); 2000; 28(3):89-93. PubMed ID: 10867376
[TBL] [Abstract][Full Text] [Related]
5. [Safety of immunotherapy and skin tests with allergens in children younger than five years].
Rodríguez Pérez N; Ambriz Moreno Mde J
Rev Alerg Mex; 2006; 53(2):47-51. PubMed ID: 16884027
[TBL] [Abstract][Full Text] [Related]
6. A comparative study of the clinical efficacy of immunotherapy and conventional pharmacological treatment for patients with perennial allergic rhinitis.
Ohashi Y; Nakai Y; Tanaka A; Kakinoki Y; Washio Y; Yamada K; Sakamoto H; Nasako Y; Hayashi M; Nakai Y
Acta Otolaryngol Suppl; 1998; 538():102-12. PubMed ID: 9879409
[TBL] [Abstract][Full Text] [Related]
7. [Clinical efficacy and safety of sublingual immunotherapy using standardized Dermatophagoides farinae extract for children with combined allergic rhinitis and asthma syndrome].
Wen CJ; Zhu MF; Ren WM; Liu XY; Qian H
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 May; 46(5):393-6. PubMed ID: 21781561
[TBL] [Abstract][Full Text] [Related]
8. Effect of allergen immunotherapy on soluble adhesion molecules.
Pereira-Santos MC; Pregal AL; Spínola-Santos A; Alonso E; Palma-Carlos ML; Palma-Carlos AG
Allerg Immunol (Paris); 2001 Jun; 33(6):225-8. PubMed ID: 11505805
[TBL] [Abstract][Full Text] [Related]
9. Topical nasal immunotherapy. Immunologic response of IgE in nasal secretion after immunotherapy with Dermatophagoides pteronyssinus.
Martín Mateos MA; Monferrer R; Muñoz López F
Allergol Immunopathol (Madr); 1990; 18(4):223-8. PubMed ID: 2264553
[TBL] [Abstract][Full Text] [Related]
10. [Current trends in the specific immunotherapy for allergic syndromes due to Dermatophagoides pteronyssinus].
Pacor ML; Biasi D
Recenti Prog Med; 1994 May; 85(5):285-8. PubMed ID: 8023008
[TBL] [Abstract][Full Text] [Related]
11. Local and systemic reactions during immunotherapy with adsorbed extracts of house dust mite in children.
Akçakaya N; Hassanzadeh A; Camcioğlu Y; Cokuğraş H
Ann Allergy Asthma Immunol; 2000 Oct; 85(4):317-21. PubMed ID: 11061476
[TBL] [Abstract][Full Text] [Related]
12. Suplatast tosilate affects the initial increase in specific IgE and interleukin-4 during immunotherapy for perennial allergic rhinitis.
Washio Y; Ohashi Y; Tanaka A; Kakinoki Y; Sugiura Y; Sakamoto H; Yamada K; Matsuda M; Uekawa M; Okamoto H; Nakai Y
Acta Otolaryngol Suppl; 1998; 538():126-32. PubMed ID: 9879412
[TBL] [Abstract][Full Text] [Related]
13. [Study on safty of standardized specific mite-allergen immunotherapy to children with allergic rhinitis and/or asthma].
Wu Y; Long Z; Huang Y; Huang X
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 Jul; 25(14):641-4. PubMed ID: 22032122
[TBL] [Abstract][Full Text] [Related]
14. Allergic rhinitis due to house dust mites: evaluation of the efficacy of specific sublingual immunotherapy.
Tonnel AB; Scherpereel A; Douay B; Mellin B; Leprince D; Goldstein N; Delecluse P; Andre C
Allergy; 2004 May; 59(5):491-7. PubMed ID: 15080829
[TBL] [Abstract][Full Text] [Related]
15. Prevention of allergic disease in childhood: clinical and epidemiological aspects of primary and secondary allergy prevention.
Halken S
Pediatr Allergy Immunol; 2004 Jun; 15 Suppl 16():4-5, 9-32. PubMed ID: 15125698
[TBL] [Abstract][Full Text] [Related]
16. Comparative study of cluster and conventional immunotherapy schedules with dermatophagoides pteronyssinus in the treatment of persistent allergic rhinitis.
Zhang L; Wang C; Han D; Wang X; Zhao Y; Liu J
Int Arch Allergy Immunol; 2009; 148(2):161-9. PubMed ID: 18802361
[TBL] [Abstract][Full Text] [Related]
17. [Analysis of adverse reactions induced by subcutaneous immunotherapy against dust mite allergy in 234 cases with allergic rhinitis and asthma].
Li MR; Wang XN; Jiang HD; Wang QY; Li YC; Lin J; Jin K; Zhang HL; Li CC
Zhonghua Er Ke Za Zhi; 2012 Oct; 50(10):726-31. PubMed ID: 23302557
[TBL] [Abstract][Full Text] [Related]
18. Immunotherapy in allergic rhinitis.
Palma-Carlos AG; Spinola-Santos A; Ferreira MB; Santos MC; Palma-Carlos ML
Allerg Immunol (Paris); 2001 Oct; 33(8):323-6. PubMed ID: 11763723
[TBL] [Abstract][Full Text] [Related]
19. [Serum eosinophil cationic protein (ECP) in patients with perennial rhinitis and atopic dermatitis, allergic to house dust mites].
Damps-Konstańska I; Gruchała-Niedoszytko M; Wilkowska A; Glén J; Konstański Z; Jassem E; Słomiński JM
Pol Merkur Lekarski; 2005 Dec; 19(114):765-8. PubMed ID: 16521419
[TBL] [Abstract][Full Text] [Related]
20. A new method of administration of topical nasal extracts. Immunoaerosol therapy.
Sánchez Palacios A; Sánchez Palacios MA; García Marrero JA
Allergol Immunopathol (Madr); 1992; 20(4):135-8. PubMed ID: 1485592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
